<?xml version="1.0" encoding="UTF-8"?><lom xmlns="http://ltsc.ieee.org/xsd/LOM" xmlns:lomfr="http://www.lom-fr.fr/xsd/LOMFR" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://ltsc.ieee.org/xsd/LOM http://www.lom-fr.fr/xsd/lomfrv1.0/std/lomfr.xsd">
<general>
<identifier>
<catalog>Canal-U_Ocms</catalog>
<entry>10868</entry>
</identifier>
<title><string language="fre"><![CDATA[Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Save life and save cost with ivabradine.]]></string></title>
<language>ENG</language>
<description>
<string language="fre"><![CDATA[Title : Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Save life and save cost with ivabradine.
Speaker: Martin COWIE, London, GBR
Abstract :  Clinical evidence suggests that an elevated resting heart rate is a risk factor for mortality and morbidity in heart failure (HF) patients. SHIfT examined the effect of adding ivabradine, a heart rate lowering therapy, to optimised standard therapy in HF patients with a heart rate ?70bpm, in sinus rhythm and with left ventricular systolic dysfunction.1 Ivabradine plus standard therapy significantly reduced the risk of a primary composite event (CV death and hospitalisation for worsening HF) versus standard therapy (hazard ratio 0.82, 95% CI: 0.75-0.90 p]]></string></description>
<keyword><string language="fre"><![CDATA[Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, Baro-stimulation, ivabradine]]></string></keyword>
<lomfr:documentType>
<lomfr:source>LOMFRv1.0</lomfr:source>
<lomfr:value>image en mouvement</lomfr:value>
</lomfr:documentType>
</general><lifeCycle>
<contribute>
<role>
<source>LOMv1.0</source>
<value>author</value>
</role>
<entity><![CDATA[BEGIN:VCARD
VERSION:3.0
CLASS:PUBLIC
REV:2021-07-06 15:37:10
FN:Martin COWIE
N:COWIE;Martin;;;
URL;TYPE=work:https://www.canal-u.tv/auteurs/cowie_martin
ROLE:author
NOTE:COWIE Martin, London, GBR&lt;br&gt;Professor Martin Cowie is Professor of Cardiology at the National Heart &amp; Lung Institute, Imperial College, London, UK and Honorary Consultant Cardiologist at the Royal Brompton Hospital, London. A founding member and pastchairman of the British Society for Heart Failure, Professor Cowie has also been a Board member (and Chair of the Education Committee) of the Heart Failure Association of the European Society of Cardiology (ESC). He advises the National Institute for Health and Clinical Excellence (NICE) on the management of heart failure. He sits on the Cardiovascular&nbsp; Round Table and the EU Affairs Committee of the European Society of Cardiology. Professor Cowie’s studies and reviews have been featured in a variety of peer-reviewed journals, including The Lancet Circulation, European Heart Journal, British Medical Journal, Heart, European Journal of Heart Failure, J American College of Cardiology and Journal of Cardiac Failure. He is a member of the editorial board of Heart, The British Journal of Diabetes and Vascular Diseases, and Cardiovascular Diabetology. He has contributed chapters to many books, and has written a book for patients entitled ‘Living with Heart Failure – a guide for patients’. His research interests centre on health technology assessment, remote monitoring and new diagnostic and treatment approaches for heart failure. 
TZ:+0200
END:VCARD
]]></entity>
<date><dateTime>2012-12-01</dateTime></date>
</contribute>
</lifeCycle>
<metaMetadata>
<metadataSchema>LOMv1.0</metadataSchema>
<metadataSchema>LOMFRv1.0</metadataSchema>
</metaMetadata>
<technical>
<format>video/mp4</format>
<location><![CDATA[https://www.canal-u.tv/video/canal_u_medecine/cardiovascular_clinical_trialists_cvct_forum_paris_2012_save_life_and_save_cost_with_ivabradine.10868]]></location>
<location><![CDATA[https://streaming-canal-u.fmsh.fr/vod/media/canalu/videos/cutms/cardiovascular.clinical.trialists.cvct.forum.paris.2012.save.life.and.save.cost.with.ivabradine._10868/1.17.cvct2012_cowie_sd.mp4]]></location>
<location><![CDATA[https://streaming-canal-u.fmsh.fr/vod/media/canalu/videos/cutms/cardiovascular.clinical.trialists.cvct.forum.paris.2012.save.life.and.save.cost.with.ivabradine._10868/1.17.cvct2012_cowie_bd.mp4]]></location>
<size>236725109</size>
<duration><duration>PT0H46M31S</duration></duration>
</technical>
<educational>
<learningResourceType>
<source>LOMv1.0</source>
<value>lecture</value>
</learningResourceType>
<context>
<source>LOMv1.0</source>
<value>higher education</value>
</context>
<context>
<source>LOMv1.0</source>
<value>formation continue</value>
</context>
</educational>
<rights>
<cost>
<source>LOMv1.0</source>
<value>no</value>
</cost>
<copyrightAndOtherRestrictions>
<source>LOMv1.0</source>
<value>no</value>
</copyrightAndOtherRestrictions>
<description>
<string language="fre"><![CDATA[Droits réservés à l'éditeur et aux auteurs. 
]]></string>
</description>
</rights>
<relation>
<kind>
<source>LOMv1.0</source>
<value>ispartof</value>
</kind>
<resource>
<identifier>
<catalog>URI</catalog>
<entry>https://www.canal-u.tv/producteurs/canal_u_medecine/cardiologie/colloque_et_evenement/cvct</entry>
</identifier>
<description>
<string language="fre"><![CDATA[CVCT 9th Global Cardiovascular Clinical Trialists Forum • Paris 2012]]></string>
</description>
</resource>
</relation>
<classification>
<purpose>
<source>LOMv1.0</source>
<value>discipline</value>
</purpose>
<taxonPath>
<source>
<string language="fre"><![CDATA[Universités Numériques Thématiques 2009 http://www.universites-numeriques.fr]]></string>
</source>
<taxon>
<id/>
<entry>
<string language="fre"/>
</entry>
</taxon>
</taxonPath>
</classification>
<classification>
<purpose>
<source>LOMv1.0</source>
<value>discipline</value>
</purpose>
<taxonPath>
<source>
<string language="fre">CDD 22e éd.</string>
<string language="eng">DDC 22nd ed.</string>
</source>
<taxon>
<id>610</id>
<entry>
<string language="fre"><![CDATA[Sciences médicales. Médecine]]></string>
</entry>
</taxon>
</taxonPath>
</classification> </lom>